Catch up on the top pharma news stories from August in our monthly round-up. From the latest on the spread of mpox to new treatment approvals, there’s plenty to discover.

We look at the latest examples of how pharma and its partners are working together to develop technology to solve key healthcare challenges.

Roche has secured European Commission approval for its drug crovalimab, marking a significant advancement in the treatment of PNH.

Bavarian Nordic has entered into a significant agreement to manufacture 440,000 additional doses of its vaccine in response to the escalating mpox outbreak.

The NHS has made commendable progress in introducing advanced therapies, but it must accelerate preparations for the next wave.

The FDA has approved Johnson & Johnson’s new chemotherapy-free combination treatment for patients with non-small cell lung cancer.

The World Health Organization has made an urgent call to pharmaceutical companies producing mpox vaccines to submit a Expressions of Interest for Emergency Use Listing (EUL).

Astellas Pharma has received approval from the UK’s MHRA for its innovative therapy designed to treat gastric cancer.